Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more information about the study results is available, it can also be found here.

- www.clinicaltrials.gov. Once you are on the website, type "NCT03811652" into the search box and click "Search".
- www.AstraZenecaClinicalTrials.com. Once you are on the website, type "D8540C00002" into the search box, and click "Find a Study".

Full Study Title: A Phase 1 Multicenter, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of MEDI7247 in Patients With Advanced or Metastatic Disease in Selected Solid Tumors
AstraZeneca Protocol Number: D8540C00002
National Clinical Trials Number: NCT03811652

MedImmune sponsored this study and has its headquarters in Gaithersburg, MD, USA.

The phone number for the AstraZeneca Information Center is +1-877-240-9479 and the email is information.center@astrazeneca.com.

Thank you!

Clinical study participants belong to a large community of people who take part in clinical research around the world. They help researchers answer important health questions and find medical treatments for patients.

The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants for clinical studies, nor is it involved in conducting clinical studies.

CISCRP | One Liberty Square, Suite 1100 â€¢ Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org